NXS 14.3% 24.0¢ next science limited

Bought in today after researching over the break. It is really...

  1. 73 Posts.
    lightbulb Created with Sketch. 8
    Bought in today after researching over the break. It is really rare to find a biotech company with so much established, non-sponsored medical literature behind their products. The studies on the acne treatment is very interesting. As an early days product can see this being scaled up to provide a real, side-effect free alternative to what's currently on the market.

    Rising prevalence of minor, but persistent MRSA infections a huge treatment opportunity as well. Exciting times.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.